Found: 32
Select item for more details and to access through your institution.
Aducanumab and Accelerated Approval: Where Do We Go From Here?
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 726, doi. 10.1002/cpt.2546
- Publication type:
- Article
Mechanism of Variability in the Response to Low Dose Aspirin.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 740, doi. 10.1002/cpt.2550
- By:
- Publication type:
- Article
Warfarin Dosing in Patients With CYP2C9*5 Variant Alleles.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 950, doi. 10.1002/cpt.2549
- By:
- Publication type:
- Article
PET as a Translational Tool in Drug Development for Neuroscience Compounds.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 774, doi. 10.1002/cpt.2548
- By:
- Publication type:
- Article
ASCPT News.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 720, doi. 10.1002/cpt.2540
- Publication type:
- Article
Understanding the Blood‐Brain Barrier and Beyond: Challenges and Opportunities for Novel CNS Therapeutics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 758, doi. 10.1002/cpt.2545
- By:
- Publication type:
- Article
Neurodegenerative Diseases: The Value of Early Predictive End Points.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 835, doi. 10.1002/cpt.2544
- By:
- Publication type:
- Article
Gene Therapy for Rare Neurological Disorders.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 743, doi. 10.1002/cpt.2543
- By:
- Publication type:
- Article
Therapeutic Innovations in Neuroscience: What's New on the Horizon?
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 715, doi. 10.1002/cpt.2547
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 713, doi. 10.1002/cpt.2538
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 718, doi. 10.1002/cpt.2537
- Publication type:
- Article
Toward Bridging Unmet Medical Need in Early Alzheimer's Disease: An Evaluation of Beta‐Amyloid (Aβ) Plaque Burden as a Potential Drug Development Tool.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 728, doi. 10.1002/cpt.2536
- By:
- Publication type:
- Article
Disease Modeling and Model‐Based Meta‐Analyses to Define a New Direction for a Phase III Program of Gantenerumab in Alzheimer's Disease.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 857, doi. 10.1002/cpt.2535
- By:
- Publication type:
- Article
Functional Loss and Mortality in Randomized Clinical Trials for Amyotrophic Lateral Sclerosis: To Combine, or Not to Combine—That is the Estimand.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 817, doi. 10.1002/cpt.2533
- By:
- Publication type:
- Article
Hemostasis Components as Therapeutic Targets in Autoimmune Demyelination.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 807, doi. 10.1002/cpt.2532
- By:
- Publication type:
- Article
Translational Approaches for Brain Delivery of Biologics via Cerebrospinal Fluid.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 826, doi. 10.1002/cpt.2531
- By:
- Publication type:
- Article
Can Innovative Trial Designs in Orphan Diseases Drive Advancement of Treatments for Common Neurological Diseases?
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 799, doi. 10.1002/cpt.2528
- By:
- Publication type:
- Article
A Systematic Review and Analysis of the Use of Polygenic Scores in Pharmacogenomics.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 919, doi. 10.1002/cpt.2520
- By:
- Publication type:
- Article
Serotonin‐Affecting Antidepressant Use in Relation to Platelet Reactivity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 909, doi. 10.1002/cpt.2517
- By:
- Publication type:
- Article
Clinical, Cellular, and Molecular Effects of Corticosteroids on the Response to Intradermal Lipopolysaccharide Administration in Healthy Volunteers.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 964, doi. 10.1002/cpt.2516
- By:
- Publication type:
- Article
Family Driven Development of Treatments for Rare Pediatric Neurological Diseases.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 736, doi. 10.1002/cpt.2507
- By:
- Publication type:
- Article
Effect of CYP3A5 and CYP3A4 Genetic Variants on Fentanyl Pharmacokinetics in a Pediatric Population.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 896, doi. 10.1002/cpt.2506
- By:
- Publication type:
- Article
The PHARMACOM‐EPI Framework for Integrating Pharmacometric Modelling Into Pharmacoepidemiological Research Using Real‐World Data: Application to Assess Death Associated With Valproate.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 840, doi. 10.1002/cpt.2502
- By:
- Publication type:
- Article
Clinical Pharmacology in Drug Development for Rare Diseases in Neurology: Contributions and Opportunities.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 786, doi. 10.1002/cpt.2501
- By:
- Publication type:
- Article
Acute Effects of Psilocybin After Escitalopram or Placebo Pretreatment in a Randomized, Double‐Blind, Placebo‐Controlled, Crossover Study in Healthy Subjects.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 886, doi. 10.1002/cpt.2487
- By:
- Publication type:
- Article
Plasma Carboxylesterase 1 Predicts Methylphenidate Exposure: A Proof‐of‐Concept Study Using Plasma Protein Biomarker for Hepatic Drug Metabolism.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 878, doi. 10.1002/cpt.2486
- By:
- Publication type:
- Article
Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 939, doi. 10.1002/cpt.2485
- By:
- Publication type:
- Article
An Interprofessional Student‐Run Medication Review Program: The Clinical STOPP/START‐Based Outcomes of a Controlled Clinical Trial in a Geriatric Outpatient Clinic.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 931, doi. 10.1002/cpt.2475
- By:
- Publication type:
- Article
Cannabis for Medical Use: Clinical Pharmacology Perspectives on Scientific and Regulatory Challenges.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 732, doi. 10.1002/cpt.2470
- By:
- Publication type:
- Article
Recommendations for Dose Selection for Adolescent Patients in Relevant Adult Oncology Clinical Trials.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 956, doi. 10.1002/cpt.2467
- By:
- Publication type:
- Article
Unanticipated CNS Safety Signal in a Placebo‐Controlled, Randomized Trial of Co‐Administered Atovaquone‐Proguanil and Amodiaquine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 867, doi. 10.1002/cpt.2404
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 705, doi. 10.1002/cpt.2295
- Publication type:
- Article